PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2016. The put-call ratio across all filers is 2.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $10,000 | -65.5% | 4,800 | -44.7% | 0.00% | -100.0% |
Q3 2016 | $29,000 | +7.4% | 8,682 | +0.0% | 0.00% | 0.0% |
Q2 2016 | $27,000 | -6.9% | 8,678 | +1.2% | 0.00% | 0.0% |
Q1 2016 | $29,000 | +45.0% | 8,578 | +53.8% | 0.00% | 0.0% |
Q4 2015 | $20,000 | 0.0% | 5,578 | +80.8% | 0.00% | 0.0% |
Q2 2015 | $20,000 | -20.0% | 3,085 | -14.4% | 0.00% | -50.0% |
Q1 2015 | $25,000 | -30.6% | 3,606 | -23.3% | 0.00% | -50.0% |
Q4 2014 | $36,000 | – | 4,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |